Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

12 results
Display

Management of vaccine safety in Korea

Choe YJ, Bae GR

  • KMID: 2391974
  • Clin Exp Vaccine Res.
  • 2013 Jan;2(1):40-45.
Although vaccination is regarded as one of the most effective public health measure to prevent and control infectious diseases, no vaccine is perfectly safe. Therefore, safety management is an essential...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vaccine industrialization in Korea: focus on major improvements and future direction

Kang JH, Cha SH

  • KMID: 2391968
  • Clin Exp Vaccine Res.
  • 2013 Jan;2(1):1-3.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical trials for vaccine development in registry of Korea Food and Drug Administration

Kang SY

  • KMID: 2391979
  • Clin Exp Vaccine Res.
  • 2013 Jan;2(1):69-70.
Based on the action plan "Ensuring a stable supply of National Immunization Program vaccines and sovereignty of biopharmaceutical products," Korea Food and Drug Administration (KFDA) has made efforts to develop...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The present and future of rabies vaccine in animals

Yang DK, Kim HH, Lee KW, Song JY

  • KMID: 2391971
  • Clin Exp Vaccine Res.
  • 2013 Jan;2(1):19-25.
An effective strategy for preventing rabies consists of controlling rabies in the host reservoir with vaccination. Rabies vaccine has proven to be the most effective weapon for coping with this...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current status of registry of vaccine clinical trials conducted by Korean investigators in ClinicalTrials.gov, database of US National Institutes of Health

Cho J, Kim BB, Bae CW, Cha SH

  • KMID: 2391975
  • Clin Exp Vaccine Res.
  • 2013 Jan;2(1):46-52.
PURPOSE: PubMed is not only includes international medical journals but also has a registration site for the ongoing clinical trials, such as ClinicalTrials.gov, under the supervision of US National Institutes...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current status of vaccine development for tularemia preparedness

Hong KJ, Park PG, Seo SH, Rhie GE, Hwang KJ

  • KMID: 2391973
  • Clin Exp Vaccine Res.
  • 2013 Jan;2(1):34-39.
Tularemia is a high-risk infectious disease caused by Gram-negative bacterium Francisella tularensis. Due to its high fatality at very low colony-forming units (less than 10), F. tularensis is considered as...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vaccines today, vaccines tomorrow: a perspective

Loucq C

  • KMID: 2391969
  • Clin Exp Vaccine Res.
  • 2013 Jan;2(1):4-7.
Vaccines are considered as one of the major contributions of the 20th century and one of the most cost effective public health interventions. The International Vaccine Institute has as a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inactivated pep27 mutant as an effective mucosal vaccine against a secondary lethal pneumococcal challenge in mice

Choi SY, Tran TD, Briles DE, Rhee DK

  • KMID: 2391977
  • Clin Exp Vaccine Res.
  • 2013 Jan;2(1):58-65.
PURPOSE: A pep27 mutant may be able to elicit mucosal immunity against pneumococcal diseases, and could be employed as an inexpensive attenuated vaccine. However, this particular mutant contains an erythromycin-resistance...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Perspectives on vaccine injury compensation program in Korea: the pediatricians' view

Jo DS, Kim JS

  • KMID: 2391976
  • Clin Exp Vaccine Res.
  • 2013 Jan;2(1):53-57.
PURPOSE: Since National Immunization Program (NIP) was implemented recently in Korea, public attention on vaccine safety is increasing. This study was aimed to investigate perceptions of pediatricians on the vaccine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Requirements for improved vaccines against foot-and-mouth disease epidemics

Park JH

  • KMID: 2391970
  • Clin Exp Vaccine Res.
  • 2013 Jan;2(1):8-18.
Inactivated foot-and-mouth disease (FMD) vaccines are currently used worldwide. With the emergence of various FMD virus serotypes and subtypes, vaccines must become more suitable for field-based uses under the current...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
H9N2 avian influenza virus in Korea: evolution and vaccination

Lee DH, Song CS

  • KMID: 2391972
  • Clin Exp Vaccine Res.
  • 2013 Jan;2(1):26-33.
Low pathogenic avian influenza (LPAI) H9N2 viruses have been circulating in the Eurasian poultry industry resulting in great economic losses due to declined egg production and moderate to high mortality....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prolonged shedding of the canine influenza H3N2 virus in nasal swabs of experimentally immunocompromised dogs

Hong M, Kang B, Na W, An D, Moon H, Kim DJ, Oh J, Park SJ, Poo H, Kim JK, Kim J, Song D

  • KMID: 2391978
  • Clin Exp Vaccine Res.
  • 2013 Jan;2(1):66-68.
PURPOSE: The avian origin canine influenza virus H3N2 has been recently isolated and found to be currently in dog population in South Korea and China. The purpose of this study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr